WoodTrust Financial Corp Increases Position in CVS Health Co. (NYSE:CVS)

WoodTrust Financial Corp lifted its holdings in shares of CVS Health Co. (NYSE:CVS) by 31.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 104,722 shares of the pharmacy operator’s stock after purchasing an additional 24,992 shares during the period. CVS Health comprises approximately 0.9% of WoodTrust Financial Corp’s investment portfolio, making the stock its 20th largest holding. WoodTrust Financial Corp’s holdings in CVS Health were worth $8,353,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Atticus Wealth Management LLC lifted its holdings in CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 219 shares during the last quarter. USA Financial Formulas lifted its stake in shares of CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. bought a new position in CVS Health in the 4th quarter worth approximately $32,000. Creekmur Asset Management LLC purchased a new position in CVS Health in the 4th quarter valued at approximately $34,000. Finally, Steph & Co. raised its holdings in CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares during the period. Institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on CVS shares. The Goldman Sachs Group decreased their price objective on CVS Health from $85.00 to $74.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Barclays decreased their price target on CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 2nd. Truist Financial reaffirmed a “buy” rating and set a $66.00 price objective (down previously from $90.00) on shares of CVS Health in a research note on Thursday, May 2nd. JPMorgan Chase & Co. lowered their target price on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research note on Thursday, May 30th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $58.00 price target on shares of CVS Health in a research report on Wednesday, June 12th. Eleven analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $75.05.

Insider Buying and Selling

In other news, Director Edward J. Ludwig purchased 1,000 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the transaction, the director now directly owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.24% of the stock is owned by insiders.

CVS Health Trading Up 1.2 %

CVS Health stock traded up $0.70 during mid-day trading on Friday, hitting $59.06. The company’s stock had a trading volume of 14,343,538 shares, compared to its average volume of 11,322,786. The business has a 50 day moving average price of $59.56 and a 200-day moving average price of $70.19. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The stock has a market cap of $74.14 billion, a price-to-earnings ratio of 10.38, a price-to-earnings-growth ratio of 0.56 and a beta of 0.53. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). The company had revenue of $88.44 billion for the quarter, compared to analysts’ expectations of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The company’s revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.20 earnings per share. As a group, analysts forecast that CVS Health Co. will post 7.02 EPS for the current year.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.